Lanean...
Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma
INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...
Gorde:
| Argitaratua izan da: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/ https://ncbi.nlm.nih.gov/pubmed/31843543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|